Rutgers receives $10 million in support of national efforts to track genetic causes of alcoholism
Rutgers University Cell and DNA Repository (RUCDR) has received a $10 million grant from the National Institute on Alcohol Abuse and alcoholism (NIAAA) to provide DNA extraction, basic genetic testing, and repository services for more than 46,000 saliva samples, in support of national research efforts to determine the genetic and environmental factors that lead to alcoholism.
The four-year grant will provide funding to the Rutgers-based repository to receive saliva samples from individuals across the United States. RUCDR will conduct DNA extraction and perform genotyping to explore genetic links to the behavior, and eventually distribute the samples to DNA sequencing laboratories that will generate whole genome sequences for each individual to more fully explore the biological connection to alcoholism.
Jay A. Tischfield, Duncan and Nancy Macmillan Professor of Genetics and director of the Human Genetics Institute of New Jersey, described the initiative as the largest NIH-supported whole genome DNA sequencing study to date.
"For the first time researchers will have robust epidemiological and biological information from large numbers of individuals so that they may correlate genetics to alcohol abuse behavior," he said. "The results will be used to formulate national policy and improve health care services."
Until now, large population-based research on the causes of alcoholism has been conducted mainly using sociological, behavioral, and limited biological data, Tischfield said. The focus of this study, which will begin collecting saliva samples in February 2012, is to identify environmental and genetic risk factors and attempt to determine how they are associated with harmful alcohol-related behaviors and abuse.
The NIAAA says that neither genes nor the environment alone can explain why any particular individual develops harmful drinking practices or alcohol use disorders and the associated chronic, often deadly, illnesses like heart disease, kidney, and liver failure and cancer that often follow. The risk of these conditions, it says, is an interaction of genes and environmental factors.
A major objective of the study, according to the NIAAA, is to determine the magnitude of the problem which will be invaluable in developing rational and scientifically based intervention and prevention programs.
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Evotec and Secarna form strategic partnership in the field of antisense therapy - Comprehensive agreement for the development of novel antisense oligonucleotide therapeutics across a broad range of targets and indications
Bile_duct
Rhenovia wins contract to lead USD 3.75 million biosimulation project
